Sopharma AD Balance Sheet

Financials in millions BGN. Fiscal year is January - December.

Millions BGN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.6	35.7	128.88	19.86	37.72
Cash & Short-Term Investments	71.6	35.7	128.88	19.86	37.72
Cash Growth	100.58%	-72.30%	549.10%	-47.37%	49.14%
Accounts Receivable	429.36	281.36	279.83	237.35	242.11
Other Receivables	25.31	24.83	16.18	13.07	16.46
Receivables	465.71	317.74	308.75	258.73	260.38
Inventory	506.61	451.41	339.33	278.58	255.95
Prepaid Expenses	5.33	3.34	3.17	2.53	2.7
Restricted Cash	0	0.03	-	-	-
Other Current Assets	41.08	41.16	6.93	12.8	14.49
Total Current Assets	1,090	849.38	787.06	572.49	571.23
Property, Plant & Equipment	413.02	392.45	357.62	376.41	362.39
Long-Term Investments	289.65	264.19	235.23	167.62	133.1
Goodwill	5.49	5.54	3.44	3.52	13.42
Other Intangible Assets	248.9	257.28	57.83	48.15	54.42
Long-Term Deferred Tax Assets	13.32	1.14	2.82	2.05	1.05
Other Long-Term Assets	16.03	20.42	19.68	19.04	13.36
Total Assets	2,080	1,796	1,514	1,254	1,205
Accounts Payable	325.01	387.66	193.84	153.45	143.64
Accrued Expenses	38.56	33.72	29.7	28.56	24.35
Short-Term Debt	333.83	194.15	200.48	160.23	223.76
Current Portion of Long-Term Debt	22.83	112.5	6.13	9.76	9.47
Current Portion of Leases	25.13	21.78	16.14	15.58	13.31
Current Income Taxes Payable	4.54	1.58	2.29	1	0.04
Current Unearned Revenue	11.24	4.75	4.41	26.5	2.59
Other Current Liabilities	79.65	15.33	156.2	12.28	6.75
Total Current Liabilities	840.79	771.47	609.19	407.35	423.89
Long-Term Debt	135.14	64.65	56.46	27.76	42.91
Long-Term Leases	95.94	87.77	71.64	69.96	41.18
Long-Term Unearned Revenue	4.66	4.36	4.93	6.16	6.78
Pension & Post-Retirement Benefits	11.7	9.78	8.1	6.31	7.3
Long-Term Deferred Tax Liabilities	6.27	8.31	4.42	6.4	8.47
Other Long-Term Liabilities	3.39	6.83	5.8	13.42	15.58
Total Liabilities	1,098	953.18	760.54	537.34	546.11
Common Stock	539.16	179.1	172.59	134.8	134.8
Retained Earnings	402.85	663.61	590.02	577.25	508.23
Treasury Stock	-18.21	-53.56	-57.45	-52.2	-50.28
Comprehensive Income & Other	27.58	28.96	33.17	44.82	54.23
Total Common Equity	951.38	818.11	738.33	704.66	646.98
Minority Interest	30.43	25	15.29	11.98	11.89
Shareholders' Equity	981.81	843.1	753.63	716.63	658.87
Total Liabilities & Equity	2,080	1,796	1,514	1,254	1,205
Total Debt	612.87	480.85	350.85	283.3	330.62
Net Cash (Debt)	-541.27	-445.16	-221.97	-263.44	-292.9
Net Cash Per Share	-1.58	-0.90	-0.54	-0.70	-0.78
Filing Date Shares Outstanding	525.53	497.23	477.34	363.96	365.23
Total Common Shares Outstanding	525.53	497.23	477.34	363.96	365.23
Working Capital	249.55	77.9	177.87	165.15	147.34
Book Value Per Share	1.81	1.65	1.55	1.94	1.77
Tangible Book Value	697	555.29	677.06	652.99	579.13
Tangible Book Value Per Share	1.33	1.12	1.42	1.79	1.59
Land	394.82	376.52	51.22	60.25	60.9
Buildings	-	-	282.35	273.56	244.85
Machinery	317.11	298.17	283.51	279.09	269.77
Construction In Progress	24.87	17.68	7.08	5.51	4.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.